CombineAble AI ltd

• Machine learning models applied to large-scale biological and chemical datasets for target discovery and drug design. • Computational biology and molecular simulation technologies supporting protein and biologics engineering. • Integrated AI-driven platforms that combine in silico modeling with experimental validation.

• Global biopharmaceutical companies and internal Insitro drug development programs. • Therapeutic areas addressed by Insitro, including oncology, neurology, and metabolic diseases. • Research collaborations requiring advanced AI, data science, and computational drug discovery capabilities.

Noam Katz - General Manager